Sameinuðu arabísku furstadæmin - enska - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

pharmaworld store united kingdom - 1 device kit - device - n/a - medical devices-medical devices

Tansanía - enska - Tanzania Medicinces & Medical Devices Authority

lab equip limited, tanzania - freezer -

Sameinuðu arabísku furstadæmin - enska - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

1 device kit -

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

labgear australia pty ltd - 40513 - freezer, ultra-low - a freezer for the storage of sample materials or reagents at extremely low temperatures. the temperature level can be as low as -86 degrees celsius. it may be provided with a built-in alarm system that warns against unexpected temperature increase.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - codeine phosphate hemihydrate, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: glycerol; propylene glycol; sucrose; purified water; potassium sorbate; hydrochloric acid; sodium hydroxide; methyl hydroxybenzoate; propyl hydroxybenzoate; ethyl hydroxybenzoate; butyl hydroxybenzoate; isobutyl hydroxybenzoate - relief of unproductive, dry and intractable coughs associated with colds and flu.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

australian natural health pharmaceuticals pty ltd - propolis resin, quantity: 200 mg/ml (equivalent: propolis, qty 400 mg/ml; equivalent: lead, qty 2 microgram/ml) - liquid, multipurpose - excipient ingredients: propylene glycol - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; maintain/support gum health

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxicillin trihydrate, quantity: 57.4 mg/ml - oral liquid, powder for - excipient ingredients: silicon dioxide; sorbitol; saccharin sodium; colloidal anhydrous silica; sodium benzoate; xanthan gum; disodium edetate; flavour - it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms: note therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e.coli (see microbiology). respiratory (acute and chronic): h.influenzae, streptococcus; s.pneumoniae; staphylococcus, non-penicillinase-producing; e.coli (see microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see microbiology), p.mirabilis and s.faecalis. gonorrhoea: n.gonorrhoeae (non-penicillinase producing). prophylaxis of endocarditis: amoxil may be used for the prophylaxis

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxicillin trihydrate, quantity: 28.7 mg/ml - oral liquid, powder for - excipient ingredients: colloidal anhydrous silica; disodium edetate; xanthan gum; saccharin sodium; sodium benzoate; sorbitol; silicon dioxide; flavour - it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms: note therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e.coli (see microbiology). respiratory (acute and chronic): h.influenzae, streptococcus; s.pneumoniae; staphylococcus, non-penicillinase-producing; e.coli (see microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see microbiology), p.mirabilis and s.faecalis. gonorrhoea: n.gonorrhoeae (non-penicillinase producing). prophylaxis of endocarditis: amoxil may be used for the prophylaxis

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sulfamethoxazole, quantity: 32.922 mg/g; trimethoprim, quantity: 6.584 mg/g - oral liquid, suspension - excipient ingredients: methyl hydroxybenzoate; sodium benzoate; carmellose sodium; sorbitol; dispersible cellulose; glycerol; polysorbate 80; ethanol; sunset yellow fcf; allura red ac; saccharin sodium; citric acid; purified water; flavour - indications as at 01 march 2002 : upper and lower respiratory tract infections; renal and urinary tract infections; genital tract infections; gastrointestinal tract infections; skin and wound infections; septicaemias, and other infections caused by sensitive organisms.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - desmopressin acetate trihydrate 100 µg/ml equivalent to 8 9µg/ml desmopressin free base - nasal drops - 100 mcg/ml - active: desmopressin acetate trihydrate 100 µg/ml equivalent to 8 9µg/ml desmopressin free base excipient: chlorobutanol hemihydrate hydrochloric acid purified water sodium chloride - minirin nasal drops solution is indicated for the treatment of central diabetes insipidus and for establishing renal concentration capacity testing.